Search research articles
Contact Us
Filters
Showing results (121-130 of 141) with videos related to
Page
of 15
Sort By:
The American Journal of Tropical Medicine and Hygiene
|
March 10, 2009
Community based parasitic screening and treatment of Sudanese refugees: application and assessment of Centers for Disease Control guidelines
Stephanie K Brodine, Anne Thomas, Robert Huang, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
April 28, 2020
Incorporation of renal function in mortality risk assessment for pulmonary arterial hypertension
Jason G E Zelt, Alomgir Hossain, Louise Y Sun, et al.
Glycobiology
|
October 3, 2024
Diversity of human salivary heparan sulfate
Charlotte B Spliid, Sanjay Mehta, Mark M Fuster, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
August 10, 2022
Medications for the treatment of pulmonary arterial hypertension: a systematic review and network meta-analysis
Tyler Pitre, Johnny Su, Sonya Cui, et al.
Advances in Therapy
|
July 12, 2022
Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension
Rogério Souza, Marion Delcroix, Nazzareno Galié, et al.
Science Advances
|
February 7, 2025
Uncoupling of Akt and mTOR signaling drives resistance to Akt inhibition in PTEN loss prostate cancers
Ninghui Mao, Young Sun Lee, Nazifa Salsabeel, et al.
JHLT Open
|
March 27, 2025
Effects of macitentan and selexipag across prognostic age groups in patients with pulmonary arterial hypertension
Richard Channick, Sarah Medrek, Marion Delcroix, et al.
The European Respiratory Journal
|
October 24, 2015
Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN
Gérald Simonneau, Richard N Channick, Marion Delcroix, et al.
JACC. Advances
|
February 25, 2025
Outcomes in Patients Receiving Treatment for Pulmonary Arterial Hypertension Associated With Repaired Congenital Heart Disease
Richard A Krasuski, Tobore Tobore, Sean Studer, et al.
Chest
|
September 28, 2016
Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial
Sanjay Mehta, Bhagavatula Kutumba Srinivasa Sastry, Rogério Souza, et al.
Page
of 15
Search research articles
Search
Showing results (121-130 of 141) with videos related to
Sort By:
Page
of 15
The American Journal of Tropical Medicine and Hygiene
|
March 10, 2009
Community based parasitic screening and treatment of Sudanese refugees: application and assessment of Centers for Disease Control guidelines
Stephanie K Brodine, Anne Thomas, Robert Huang, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
April 28, 2020
Incorporation of renal function in mortality risk assessment for pulmonary arterial hypertension
Jason G E Zelt, Alomgir Hossain, Louise Y Sun, et al.
Glycobiology
|
October 3, 2024
Diversity of human salivary heparan sulfate
Charlotte B Spliid, Sanjay Mehta, Mark M Fuster, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
August 10, 2022
Medications for the treatment of pulmonary arterial hypertension: a systematic review and network meta-analysis
Tyler Pitre, Johnny Su, Sonya Cui, et al.
Advances in Therapy
|
July 12, 2022
Long-Term Safety, Tolerability and Survival in Patients with Pulmonary Arterial Hypertension Treated with Macitentan: Results from the SERAPHIN Open-Label Extension
Rogério Souza, Marion Delcroix, Nazzareno Galié, et al.
Science Advances
|
February 7, 2025
Uncoupling of Akt and mTOR signaling drives resistance to Akt inhibition in PTEN loss prostate cancers
Ninghui Mao, Young Sun Lee, Nazifa Salsabeel, et al.
JHLT Open
|
March 27, 2025
Effects of macitentan and selexipag across prognostic age groups in patients with pulmonary arterial hypertension
Richard Channick, Sarah Medrek, Marion Delcroix, et al.
The European Respiratory Journal
|
October 24, 2015
Incident and prevalent cohorts with pulmonary arterial hypertension: insight from SERAPHIN
Gérald Simonneau, Richard N Channick, Marion Delcroix, et al.
JACC. Advances
|
February 25, 2025
Outcomes in Patients Receiving Treatment for Pulmonary Arterial Hypertension Associated With Repaired Congenital Heart Disease
Richard A Krasuski, Tobore Tobore, Sean Studer, et al.
Chest
|
September 28, 2016
Macitentan Improves Health-Related Quality of Life for Patients With Pulmonary Arterial Hypertension: Results From the Randomized Controlled SERAPHIN Trial
Sanjay Mehta, Bhagavatula Kutumba Srinivasa Sastry, Rogério Souza, et al.
Page
of 15